Arcutis Biotherapeutics Inc (ARQT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
14.62 -0.19 (-1.28%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 14.65 +0.03 (+0.21%) 17:30 ET
for Fri, Mar 14th, 2025
Fiscal Year End Date: 12/31
12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
Operating Expenses | 43,132 | 19,735 | 4,106 | 0 | 0 |
Operating Income | -43,132 | -19,735 | -4,106 | N/A | N/A |
Other Income | 1,136 | 480 | -872 | 0 | 0 |
Pre-tax Income | -41,996 | -19,255 | -4,978 | 0 | 0 |
Net Income Continuous | -41,996 | -19,255 | -4,978 | N/A | N/A |
Net Income | $-41,996 | $-19,255 | $-4,978 | $N/A | $N/A |
EPS Basic Total Ops | -22.78 | -15.53 | -7.16 | N/A | N/A |
EPS Basic Continuous Ops | -22.78 | -15.53 | -7.16 | N/A | N/A |
EPS Diluted Total Ops | -22.78 | -15.53 | -7.16 | N/A | N/A |
EPS Diluted Continuous Ops | -22.78 | -15.53 | -7.16 | N/A | N/A |
EPS Diluted Before Non-Recurring Items | -22.78 | N/A | N/A | N/A | N/A |
EBITDA(a) | $-43,418 | $-19,749 | $-4,106 | $N/A | $N/A |